ZNF766 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.788300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.218420E-01
Normal-vs-Stage2
9.731700E-02
Normal-vs-Stage3
1.220210E-01
Normal-vs-Stage4
7.103600E-01
Stage1-vs-Stage2
6.704400E-01
Stage1-vs-Stage3
2.079400E-01
Stage1-vs-Stage4
3.214800E-01
Stage2-vs-Stage3
3.894800E-01
Stage2-vs-Stage4
1.912550E-01
Stage3-vs-Stage4
1.755030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.935600E-02
Normal-vs-AfricanAmerican
6.756300E-02
Normal-vs-Asian
3.764000E-01
Caucasian-vs-AfricanAmerican
7.863200E-01
Caucasian-vs-Asian
4.796000E-01
AfricanAmerican-vs-Asian
5.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.966100E-02
Normal-vs-Female
1.009200E-01
Male-vs-Female
9.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.820400E-01
Normal-vs-Age(41-60Yrs)
1.649380E-01
Normal-vs-Age(61-80Yrs)
8.702000E-02
Normal-vs-Age(81-100Yrs)
7.660600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.191000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.978400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.517600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.587500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.202000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.355580E-02
Normal-vs-Daily Drinker
9.107800E-02
Normal-vs-Weekly Drinker
1.500450E-02
Normal-vs-Occasional Drinker
6.126000E-01
Normal-vs-Social Drinker
4.011600E-02
Non Drinker-vs-Daily Drinker
1.424190E-01
Non Drinker-vs-Weekly Drinker
9.837200E-01
Non Drinker-vs-Occasional Drinker
1.903440E-03
Non Drinker-vs-Social Drinker
8.513900E-02
Daily Drinker-vs-Weekly Drinker
2.194600E-01
Daily Drinker-vs-Occasional Drinker
7.247700E-02
Daily Drinker-vs-Social Drinker
8.100800E-01
Weekly Drinker-vs-Occasional Drinker
1.189950E-02
Weekly Drinker-vs-Social Drinker
9.720400E-02
Occasional Drinker-vs-Social Drinker
9.935800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.343600E-02
Normal-vs-Grade 2
1.522160E-03
Normal-vs-Grade 3
5.440500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.466200E-01
Grade 1-vs-Grade 3
2.269600E-01
Grade 1-vs-Grade 4
4.343600E-02
Grade 2-vs-Grade 3
2.105800E-01
Grade 2-vs-Grade 4
1.522160E-03
Grade 3-vs-Grade 4
5.440500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.459200E-03
Normal-vs-NonDiabetic
1.080980E-01
Diabetic-vs-NonDiabetic
2.449900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.797600E-02
Normal-vs-NoPancreatitis
8.029600E-02
Pancreatitis-vs-NoPancreatitis
5.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.542300E-02
Normal-vs-N1
9.928500E-02
N0-vs-N1
6.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.877200E-01
Normal-vs-TP53-NonMutant
1.197760E-01
TP53-Mutant-vs-TP53-NonMutant
1.799270E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
